News for Baudax Bio, Inc. (BXRX)

NEW YORK, Feb. 13, 2024 (GLOBE NEWSWIRE) -- The Nasdaq Stock Market announced today that it will delist the common shares of Sono Group N.V. Sono Group N.V.'s securities were suspended on July 21, 2023, and have not

NEW YORK, Feb. 13, 2024 (GLOBE NEWSWIRE) -- The Nasdaq Stock Market announced today that it will delist the common shares of Sono Group N.V. Sono Group...

Baudax Bio, Inc. reported earnings results for the third quarter and nine months ended September 30, 2023. For the third quarter, the company reported net loss was USD 1.93 million compared to USD...

Baudax Bio, Inc. dropped from S&P TMI Index...

On Wednesday, 311 stocks hit new 52-week lows.

U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining 1% on Thursday. The Dow traded up 0.58% to 33,745.23 while the NASDAQ rose 1% to 13,223.61. The S&P 500 also rose, gaining, 0.81% to 4,309.27.

Baudax Bio, Inc. (BXRX), a biotechnology company, announced Thursday that the U.S. Food and Drug Administration or FDA has granted orphan drug designation to its lead clinical candidate TI-168 for the treatment of Hemophilia A with inhibitors.

Baudax Bio, Inc. (BXRX) appears to have found support after losing some value lately, as indicated by the formation of a hammer chart. In addition to this technical chart pattern, strong agreement among Wall Street analysts in revising earnings estimates higher enhances the stock's potential for a turnaround in the near term.

Potential pipeline candidates is a key factor driving anti-inflammatory drugs market revenue growth ...

MALVERN, Pa., Aug. 23, 2023 (GLOBE NEWSWIRE) -- Baudax Bio, Inc. (the “Company” or “Baudax Bio”) (NASDAQ: BXRX), a biotechnology company focused on...

U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.84%

Management's Discussion and Analysis of Financial Condition and Results of Operations You should read the following discussion and analysis of our financial condition and results of operations together with our consolidated financia...

The stock market crash of 2022 significantly depressed US equities’ valuations. In this backdrop, many believe now is the right time to buy stocks for long-term benefits.

The following are some of the stocks making big moves in Thursday's pre-market trading (as of 07.00 A.M. ET)..

The following are some of the stocks making big moves in Thursday's pre-market trading (as of 07.00 A.M. ET)..

U.S. stocks traded slightly lower this morning following the release of PPI data

Gainers Bright Green Corp. (NASDAQ: BGXX) jumped 90.5% to close at $48.08 on Wednesday. Bright Green Corporation, went public on the NASDAQ Tuesday, becoming the first U.S. plant-touching company to list on a major U.S. stock exchange.

On Thursday, 615 stocks hit new 52-week lows. Noteable 52-Week Lows: Sea (NYSE:SE) is the largest company in terms of market cap to set a new ...

The following are some of the stocks making big moves in Thursday's pre-market trading (as of 05.45 A.M. EDT)..